Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Demand for Newborn Screening Rising Amid Surging Cases of Infant Disorders: Fact.MR

This image opens in the lightbox

News provided by

Fact.MR

10 Jun, 2021, 15:00 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, June 10, 2021 /PRNewswire/ -- Award-winning market research firm Fact.MR forecasts a healthy growth outlook for global newborn screening market over the forecast period of 2021 and 2031. The market is poised to expand at a CAGR of over 8% to surpass a valuation of US$ 1 Bn by 2031.

Increasing birth rates across the globe and high investment in the newborn health infrastructure are the primary drivers for the growth of newborn screening market.

With the increasing birth rates, there's a surge in the cases of infant disorders such as hearing impairment, congenital thyroidisim and other hormonal disorders. Thereby, improving the adoption of newborn screening tests.

 Demand for effective diagnostic solutions has compounded with rising mortality rates among newborns, prompting healthcare professionals to increase the investment in the development of advanced newborn screening tests.

Manufacturers are increasing their research and development activities to foray into emerging economies such as India, China and Brazil amid the increasing birth rates in the countries.

According to the World Health Organization, India recorded 17.3 births per 1000 people in the year 2020, which is nearly 1/5th of global annual childbirths. With increasing birth rates, there's a rising prevalence of congenital hypothyroidism and phenylketonuria among infants.

Subsequently, government is increasing the newborn healthcare infrastructure and providing funding and packages for the newborn screenings. Thereby, bolstering market growth.

"Rising infant birth as well as mortality rates in the emerging economies such as India, China and Brazil are providing ample of opportunities for the newborn screening market in the region," says a Fact.MR analyst.   

Key Takeaways

  • In terms of product, newborn screening consumables demand is poised to expand at nearly 8% CAGR through 2031
  • Based on technology, immunoassay-and enzymatic assay, collectively, are expected to lead the segment, exhibiting a CAGR of over 7% during the forecast period
  • In terms of test, dry blood spot newborn screening is poised to acquire precedence, registering growth at 9% CAGR
  • The U.S. newborn screening market is likely to generate significant opportunities for the market players, expanding at a CAGR of 5% over the forecast period
  • Increasing government initiatives to curb the infant mortality rates across India will bolster the demand of newborn screening, generating around 30% of revenue
  • China is anticipated to lead the East Asia market, accounting for over 50% of market share owing to the increasing cases of congenital hypothyroidism in the region

Competitive Landscape       

Key players are focusing on expansion of their product portfolios through acquisition of existing players and forming alliance with top companies. Manufacturers are also reliant on strategic partnerships and mergers to expand their global reach and maintain their position in the industry.

In September 2020, PerkinElmer received approval for its new launch of CE-IVD approval for EONIS screening assay used to screen spinal muscular atrophy, X-linked agammaglobulinemia, and severe combined immunodeficiency among newborns.

In February 2021, LifeCell, India's largest stem cell back announced relief fund and special offers to the parents for the screening of newborns. Baby shield Newborn Screening combines biochemical testing of 100+ metabolic and genetic conditions with confirmatory genetic testing.

In December 2019, PerkinElmer received the U.S. Food and Drugs Administration approval for GSP Neonatal Creatine Kinase-MM kit for newborn screening affected by Duchenne muscular dystrophy.

Prominent newborn screening manufacturers listed in Fact.MR's report are listed below:

  • Bio-Rad Laboratories
  • Danaher Corporation
  • Medtronic Plc.
  • Chromsystems Instruments & Chemicals GmbH
  • Trivitron Healthcare
  • Baebies
  • Masimo Corporation
  • Natus Medical Inc.
  • RECIPE Chemicals + Instruments GmbH

More Valuable Insights on Newborn Screening market

Fact.MR, in its latest study, offers a detailed segmentation on the global newborn screening market. The study divulges essential insights on the major trends and opportunities of global newborn screening market. To gain a better perspective on the market potential and scope, the market is classified on the basis of:

Product Type

  • Newborn Screening Instruments
    • Disorder Screening Instruments
      • Fully Automated Newborn Screening Instruments
      • Other Newborn Screening Instruments (Semi-automated Instruments, Shakers, Incubators, etc.)
    • Hearing Screening Instruments
      • Newborn Screening Accessories
      • Newborn Screening Devices
    • Pulse Oximeters
  • Consumables
    • Newborn Screening Assay Kits & Reagents
    • Other Newborn Screening Consumables (Columns and Screening Cards)

Test Type

  • Dry Blood Spot Newborn Screening Tests
  • Newborn Hearing Screening Tests
  • Critical Congenital Heart Disease (CCHD) Screening Tests

Technology

  • Newborn Immunoassays & Enzymatic Screening Tests
  • Tandem Mass Spectrometry
  • Molecular Assays
  • Newborn Hearing Screening Technologies
  • Pulse Oximetry
  • Other Newborn Screening Technologies (Fluorescence, Gel Electrophoresis, etc.)

End User

  • Newborn Screening at Clinical Laboratories
  • Newborn Screening at Hospitals

By Region

  • North America (U.S. and Canada)
  • Latin America (Brazil, Mexico, Argentina, and Rest of Latin America)
  • Europe (Germany, U.K., France, Spain, Italy, and Rest of Europe)
  • East Asia (China, Japan, and South Korea)
  • South Asia (India, ASEAN, and Rest of South Asia)
  • Oceania (Australia and Rest of Oceania)
  • Middle East and Africa (GCC, South Africa, and Rest of MEA)

Key Questions Covered in the Report

  • What are the growth prospects for newborn screening products manufacturers during the forecast period?
  • Which are the prominent manufacturers operating in the newborn screening market?
  • Which region will be the most lucrative for newborn screening markets?
  • Which technology of newborn screening will be the most preferred in the upcoming decade?
  • Which test type of newborn screening market will have the highest market share during the forecast period?
  • What are the key challenges faced by newborn screening manufacturers?
  • What is the impact of Covid-19 on newborn screening market?

Explore Fact.MR's Coverage on the Healthcare Domain 

Neonatal Monitoring Equipment Market - Neonatal monitoring technology is gaining popularity since it is critical in guaranteeing the health of newborn babies. Neonates' high vulnerability to even small diseases has necessitated continual care, and neonatal monitoring technology effectively meets this demand. Infant intensive care units are concerned about rising neonatal mortality rates, asphyxia, and problems in premature births (NICUs).

Fetal and Neonatal Heart Monitor Market - Given the substantial efforts made to interpret prenatal and neonatal heart rates in order to prevent hypoxia, comprehensive diagnosis of heart rate pattern abnormalities, particularly those induced by metabolic abnormalities, remains a difficulty. New research approaches are being developed to make prenatal and neonatal hypoxia care more cost-effective, as a way to avoid the costly and risky practice of using a computerized cardiotocograph (CTG).

Neonatal Ventilator Market - Preterm deliveries are connected with a high mortality rate, which is mostly owing to inadequate respiratory monitoring and nutrient intakes. Furthermore, infants' lungs are tiny and require additional support to regulate their breathing. This has led to the development of neonatal ventilators that can deliver the appropriate amount of oxygen to the lungs, allowing newborns to survive even when their respiratory systems are compromised.

About Fact.MR

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

Contact:

Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Logo: https://mma.prnewswire.com/media/713666/FactMR_Logo.jpg

Modal title

Also from this source

Bisabolene Market is Forecasted to Reach US$ 4.6 Million by 2034, Expanding at a CAGR of 3.9% | Fact.MR Report

According to a new research report published by Fact.MR, the global Bisabolene Market was valued at US$ 3 million in 2023 and has been forecasted to...

Hyaluronic Acid Raw Material Market is projected to grow at a CAGR of 5.2%, Reaching a value of $11.7 billion by 2034 | Fact.MR Report

The global Hyaluronic Acid Raw Material Market has been valued at US$ 7.05 billion in 2024, as stated in the recently updated industry analysis by...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.